Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares. The filing date is March 30, 2026, covering a share repurchase executed on March 27, 2026. The transaction was conducted through BNP Paribas SA as part of an existing buyback programme established under a non-discretionary agreement announced on February 17, 2026.
Key Financial Metrics
The filing details a specific share repurchase event rather than comprehensive financial results. Key metrics for the transaction are as follows:
- Shares Purchased: 340,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 2,024.00 GBp; highest price paid was 2,060.00 GBp.
- Average Price: Volume-weighted average price paid was 2,043.51 GBp.
- Treasury Holdings: Following this purchase, GSK holds 255,432,615 ordinary shares in treasury.
- Shares in Issue: 4,060,747,166 ordinary shares (excluding treasury shares).
- Voting Rights: Treasury shares represent 6.29% of total voting rights.
The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
Since the commencement of the current buyback programme on February 17, 2026, the Company has purchased a total of 15,541,521 ordinary shares. The March 27 transaction increased the treasury share count, reducing the number of shares in issue and increasing the percentage of voting rights held in treasury to 6.29%.
Guidance, Outlook, and Risks
The filing contains no specific financial guidance or management commentary regarding future operational performance. It includes a standard cautionary statement noting that forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from projections. Investors are referred to the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2025 for a detailed description of these risks.
Investor Verification Checklist
- Verify the total number of shares purchased under the buyback programme since February 17, 2026 (15,541,521 shares).
- Confirm the current percentage of voting rights held in treasury (6.29%) for disclosure threshold calculations under FCA rules.
- Review the Annual Report on Form 20-F for 2025 for detailed risk factors referenced in the cautionary statement.
- Check the remaining authorization or budget for the buyback programme, as this information is not explicitly stated in this filing.